China's Livzon to acquire 65 per cent of pharmaceutical firm Imexpharm
May 27, 2025 | 11:19
China's Livzon Pharmaceutical Group Inc. will spend VND5.73 trillion ($221 million) to acquire almost 65 per cent of Imexpharm Corporation.
Mobile Version